The Genetic Epidemiology Network of Arteriopathy (GENOA) was initiated in 1995 to study the genetics of hypertension and its arteriosclerotic complications in sibships. Arteriosclerosis (i.e., atherosclerosis and arteriolosclerosis) of the cardiac, cerebral, renal, and peripheral arteries leads to target organ damage and clinical sequelae such as heart attack, heart failure, stroke, dementia, chronic kidney disease, and claudication. In this application, we propose to conduct an exome-wide association study (Aim 1) and transcriptomic profiling (Aim 2) as cost-effective methods of identifying and studying functional variations in the 1020 GENOA African-American and non-Hispanic White sibships (N=2912) who are at high risk of developing a wide range of arteriosclerotic clinical outcomes. The GENOA cohort provides a unique opportunity to assess the phenotypic impact of rare variants that naturally replicate within a sibship, but may not be seen again even in large epidemiological populations. The GENOA community-based sampling of hypertensive sibships was explicitly designed to study the genetics of multiple late-onset arteriosclerotic diseases that typically become clinically apparent only in the upper generations of families. In order to ultimately identify """"""""at risk"""""""" individuals and estimate the cumulative burden of genetic risk allele in two U.S. populations (Aim 3) we will estimate genetic risk scores and assess the attributable fraction of phenotypic variation explained by these new genetic variations.

Public Health Relevance

In this project we will use state-of-the-art exome-wide association study (EWAS) to identify the genetic mutations that make some families have a very high risk of developing heart attacks, strokes, dementia, and kidney disease because of arteriosclerosis.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Cardiovascular and Sleep Epidemiology Study Section (CASE)
Program Officer
Jaquish, Cashell E
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Public Health & Prev Medicine
Schools of Public Health
Ann Arbor
United States
Zip Code
Olfson, E; Saccone, N L; Johnson, E O et al. (2016) Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans. Mol Psychiatry 21:601-7
Broadaway, K Alaine; Cutler, David J; Duncan, Richard et al. (2016) A Statistical Approach for Testing Cross-Phenotype Effects of Rare Variants. Am J Hum Genet 98:525-40
Ligthart, Symen; Marzi, Carola; Aslibekyan, Stella et al. (2016) DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases. Genome Biol 17:255
Ware, Erin B; Riehle, Ellen; Smith, Jennifer A et al. (2015) SLC2A9 Genotype Is Associated with SLC2A9 Gene Expression and Urinary Uric Acid Concentration. PLoS One 10:e0128593
(2015) Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nat Genet 47:1294-303
Perinpam, Majuran; Ware, Erin B; Smith, Jennifer A et al. (2015) Effect of Demographics on Excretion of Key Urinary Factors Related to Kidney Stone Risk. Urology 86:690-6
Smith, Jennifer A; Ware, Erin B; Middha, Pooja et al. (2015) Current Applications of Genetic Risk Scores to Cardiovascular Outcomes and Subclinical Phenotypes. Curr Epidemiol Rep 2:180-190
Zhao, Wei; Smith, Jennifer A; Mao, Guangmei et al. (2015) The cis and trans effects of the risk variants of coronary artery disease in the Chr9p21 region. BMC Med Genomics 8:21
Epstein, Michael P; Duncan, Richard; Ware, Erin B et al. (2015) A statistical approach for rare-variant association testing in affected sibships. Am J Hum Genet 96:543-54